The NMDA receptor NR2B subtype selective antagonist Ro 25-6981 aggravates paroxysmal dyskinesia in the dt sz mutant

Author: Richter A.  

Publisher: Elsevier

ISSN: 0014-2999

Source: European Journal of Pharmacology, Vol.458, Iss.1, 2003-01, pp. : 107-110

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract